J Pharm Sci

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles.
 

https://www.sciencedirect.com/science/article/pii/S0022354921005529?dgcid=coauthor

January 31th, 2022

hiv.png

J Pharm Sci

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 1: Model for the Free-Drug Mixture
 

https://www.sciencedirect.com/science/article/abs/pii/S0022354921005475?dgcid=coauthor

December 9th, 2021

hiv.png


J Pharm Sci

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates

https://www.sciencedirect.com/science/article/pii/S0022354920307486

January 15th, 2021
 

1601999340-Document.png

Frontiers in Pharmacology
Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
https://www.frontiersin.org/articles/10.3389/fphar.2020.603242/full

January 15th, 2021
 

hiv.png
cancer.png
hiv.png